Siemens Healthineers – Capital Expenditure

Quarterly charts & data from official filings

Timeframe

Capital expenditure

Capital expenditureTable view

Earnings release date
Capital expenditure
Earnings release date:07 May. 26
Capital expenditure:
182,000,000 €+13.0%
Earnings release date:05 Feb. 26
Capital expenditure:
161,000,000 €-38.5%
Earnings release date:05 Nov. 25
Capital expenditure:
262,000,000 €+37.2%
Earnings release date:30 Jul. 25
Capital expenditure:
191,000,000 €-2.1%
Earnings release date:07 May. 25
Capital expenditure:
195,000,000 €+14.7%
Earnings release date:06 Feb. 25
Capital expenditure:
170,000,000 €-20.2%
Earnings release date:06 Nov. 24
Capital expenditure:
213,000,000 €+15.1%
Earnings release date:31 Jul. 24
Capital expenditure:
185,000,000 €+11.4%
Earnings release date:07 May. 24
Capital expenditure:
166,000,000 €+25.8%
Earnings release date:01 Feb. 24
Capital expenditure:
132,000,000 €-45.2%
Earnings release date:08 Nov. 23
Capital expenditure:
241,000,000 €+25.5%
Earnings release date:02 Aug. 23
Capital expenditure:
192,000,000 €-6.3%
Earnings release date:10 May. 23
Capital expenditure:
205,000,000 €+2.5%
Earnings release date:02 Feb. 23
Capital expenditure:
200,000,000 €-29.6%
Earnings release date:09 Nov. 22
Capital expenditure:
284,000,000 €+52.7%
Earnings release date:03 Aug. 22
Capital expenditure:
186,000,000 €

Revenue by segment

Revenue by segmentTable view

Earnings release date
Imaging
Diagnostics
Varian
Advanced Therapies
Precision Therapy
Reconciliation to consolidated financial statements
Total
Earnings release date:07 May. 26
Imaging:
2,949,000,000 €+6.5%
Diagnostics:
984,000,000 €+0.0%
Varian:
–
Advanced Therapies:
–
Precision Therapy:
1,701,000,000 €+6.1%
Reconciliation to consolidated financial statements:
46,000,000 €+4.5%
Total:
5,680,000,000 €+5.2%
Earnings release date:05 Feb. 26
Imaging:
2,770,000,000 €-21.1%
Diagnostics:
984,000,000 €-10.4%
Varian:
–
Advanced Therapies:
–
Precision Therapy:
1,603,000,000 €
Reconciliation to consolidated financial statements:
44,000,000 €+33.3%
Total:
5,401,000,000 €-14.6%
Earnings release date:05 Nov. 25
Imaging:
3,512,000,000 €+12.9%
Diagnostics:
1,098,000,000 €+3.7%
Varian:
1,087,000,000 €+11.1%
Advanced Therapies:
591,000,000 €+22.1%
Precision Therapy:
–
Reconciliation to consolidated financial statements:
33,000,000 €+3.1%
Total:
6,321,000,000 €+11.6%
Earnings release date:30 Jul. 25
Imaging:
3,110,000,000 €-1.4%
Diagnostics:
1,059,000,000 €-5.6%
Varian:
978,000,000 €-6.1%
Advanced Therapies:
484,000,000 €-12.3%
Precision Therapy:
–
Reconciliation to consolidated financial statements:
32,000,000 €-22.0%
Total:
5,663,000,000 €-4.2%
Earnings release date:07 May. 25
Imaging:
3,153,000,000 €+8.6%
Diagnostics:
1,122,000,000 €+5.1%
Varian:
1,041,000,000 €+7.0%
Advanced Therapies:
552,000,000 €+10.8%
Precision Therapy:
–
Reconciliation to consolidated financial statements:
41,000,000 €+0.0%
Total:
5,909,000,000 €+7.8%
Earnings release date:06 Feb. 25
Imaging:
2,902,000,000 €-15.3%
Diagnostics:
1,068,000,000 €-6.9%
Varian:
973,000,000 €-12.9%
Advanced Therapies:
498,000,000 €-16.0%
Precision Therapy:
–
Reconciliation to consolidated financial statements:
41,000,000 €-6.8%
Total:
5,482,000,000 €-13.4%
Earnings release date:06 Nov. 24
Imaging:
3,426,000,000 €+19.5%
Diagnostics:
1,147,000,000 €+3.5%
Varian:
1,117,000,000 €+20.5%
Advanced Therapies:
593,000,000 €+23.8%
Precision Therapy:
–
Reconciliation to consolidated financial statements:
44,000,000 €+0.0%
Total:
6,327,000,000 €+16.6%
Earnings release date:31 Jul. 24
Imaging:
2,866,000,000 €+0.7%
Diagnostics:
1,108,000,000 €+0.5%
Varian:
927,000,000 €+1.9%
Advanced Therapies:
479,000,000 €-8.8%
Precision Therapy:
–
Reconciliation to consolidated financial statements:
44,000,000 €-12.0%
Total:
5,424,000,000 €-0.2%
Earnings release date:07 May. 24
Imaging:
2,847,000,000 €+5.9%
Diagnostics:
1,103,000,000 €+4.3%
Varian:
910,000,000 €-0.1%
Advanced Therapies:
525,000,000 €+10.8%
Precision Therapy:
–
Reconciliation to consolidated financial statements:
50,000,000 €+16.3%
Total:
5,435,000,000 €+5.0%
Earnings release date:01 Feb. 24
Imaging:
2,689,000,000 €-16.2%
Diagnostics:
1,058,000,000 €-12.5%
Varian:
911,000,000 €-10.4%
Advanced Therapies:
474,000,000 €-16.7%
Precision Therapy:
–
Reconciliation to consolidated financial statements:
43,000,000 €-15.7%
Total:
5,175,000,000 €-14.5%
Earnings release date:08 Nov. 23
Imaging:
3,210,000,000 €+16.6%
Diagnostics:
1,209,000,000 €+10.8%
Varian:
1,017,000,000 €+21.1%
Advanced Therapies:
569,000,000 €+19.0%
Precision Therapy:
–
Reconciliation to consolidated financial statements:
51,000,000 €+30.8%
Total:
6,056,000,000 €+16.4%
Earnings release date:02 Aug. 23
Imaging:
2,753,000,000 €-1.6%
Diagnostics:
1,091,000,000 €+0.9%
Varian:
840,000,000 €-10.0%
Advanced Therapies:
478,000,000 €-3.4%
Precision Therapy:
–
Reconciliation to consolidated financial statements:
39,000,000 €+5.4%
Total:
5,201,000,000 €-2.7%
Earnings release date:10 May. 23
Imaging:
2,799,000,000 €+6.0%
Diagnostics:
1,081,000,000 €-5.8%
Varian:
933,000,000 €+21.2%
Advanced Therapies:
495,000,000 €+4.7%
Precision Therapy:
–
Reconciliation to consolidated financial statements:
37,000,000 €-21.3%
Total:
5,345,000,000 €+5.3%
Earnings release date:02 Feb. 23
Imaging:
2,641,000,000 €-16.1%
Diagnostics:
1,147,000,000 €-20.5%
Varian:
770,000,000 €-6.1%
Advanced Therapies:
473,000,000 €-17.9%
Precision Therapy:
–
Reconciliation to consolidated financial statements:
47,000,000 €+235.7%
Total:
5,078,000,000 €-15.4%
Earnings release date:09 Nov. 22
Imaging:
3,147,000,000 €+24.7%
Diagnostics:
1,442,000,000 €+2.3%
Varian:
820,000,000 €+2.6%
Advanced Therapies:
576,000,000 €+28.6%
Precision Therapy:
–
Reconciliation to consolidated financial statements:
14,000,000 €+133.3%
Total:
5,999,000,000 €+15.7%
Earnings release date:03 Aug. 22
Imaging:
2,524,000,000 €
Diagnostics:
1,409,000,000 €
Varian:
799,000,000 €
Advanced Therapies:
448,000,000 €
Precision Therapy:
–
Reconciliation to consolidated financial statements:
6,000,000 €
Total:
5,186,000,000 €

Revenue by geographic location

Revenue by geographic locationTable view

Earnings release date
Europe, C.I.S., Africa, Middle East (EMEA)
Americas
Asia, Australia
Asia Pacific Japan
China
Total
Earnings release date:07 May. 26
Europe, C.I.S., Africa, Middle East (EMEA):
1,910,000,000 €+5.4%
Americas:
2,534,000,000 €+6.2%
Asia, Australia:
–
Asia Pacific Japan:
713,000,000 €+9.2%
China:
525,000,000 €-4.5%
Total:
5,682,000,000 €+5.2%
Earnings release date:05 Feb. 26
Europe, C.I.S., Africa, Middle East (EMEA):
1,812,000,000 €-14.5%
Americas:
2,387,000,000 €-13.0%
Asia, Australia:
–
Asia Pacific Japan:
653,000,000 €-21.0%
China:
550,000,000 €-12.6%
Total:
5,402,000,000 €-14.5%
Earnings release date:05 Nov. 25
Europe, C.I.S., Africa, Middle East (EMEA):
2,120,000,000 €+16.7%
Americas:
2,745,000,000 €+8.0%
Asia, Australia:
–
Asia Pacific Japan:
827,000,000 €+20.9%
China:
629,000,000 €+1.5%
Total:
6,321,000,000 €+11.6%
Earnings release date:30 Jul. 25
Europe, C.I.S., Africa, Middle East (EMEA):
1,816,000,000 €-0.5%
Americas:
2,542,000,000 €-3.2%
Asia, Australia:
–
Asia Pacific Japan:
684,000,000 €-18.7%
China:
620,000,000 €+0.8%
Total:
5,662,000,000 €-4.2%
Earnings release date:07 May. 25
Europe, C.I.S., Africa, Middle East (EMEA):
1,825,000,000 €+1.8%
Americas:
2,627,000,000 €+10.9%
Asia, Australia:
–
Asia Pacific Japan:
841,000,000 €+19.6%
China:
615,000,000 €-0.5%
Total:
5,908,000,000 €+7.8%
Earnings release date:06 Feb. 25
Europe, C.I.S., Africa, Middle East (EMEA):
1,793,000,000 €-13.3%
Americas:
2,368,000,000 €-12.5%
Asia, Australia:
–
Asia Pacific Japan:
703,000,000 €-18.8%
China:
618,000,000 €-10.0%
Total:
5,482,000,000 €-13.4%
Earnings release date:06 Nov. 24
Europe, C.I.S., Africa, Middle East (EMEA):
2,069,000,000 €+17.0%
Americas:
2,706,000,000 €+12.9%
Asia, Australia:
–
Asia Pacific Japan:
866,000,000 €+33.4%
China:
687,000,000 €+12.4%
Total:
6,328,000,000 €+16.7%
Earnings release date:31 Jul. 24
Europe, C.I.S., Africa, Middle East (EMEA):
1,768,000,000 €-2.3%
Americas:
2,396,000,000 €+6.3%
Asia, Australia:
–
Asia Pacific Japan:
649,000,000 €-16.6%
China:
611,000,000 €+2.7%
Total:
5,424,000,000 €-0.2%
Earnings release date:07 May. 24
Europe, C.I.S., Africa, Middle East (EMEA):
1,810,000,000 €+0.9%
Americas:
2,253,000,000 €+8.7%
Asia, Australia:
–
Asia Pacific Japan:
778,000,000 €+19.5%
China:
595,000,000 €-9.4%
Total:
5,436,000,000 €+5.0%
Earnings release date:01 Feb. 24
Europe, C.I.S., Africa, Middle East (EMEA):
1,794,000,000 €-10.4%
Americas:
2,073,000,000 €-17.2%
Asia, Australia:
–
Asia Pacific Japan:
651,000,000 €-21.7%
China:
657,000,000 €-8.4%
Total:
5,175,000,000 €-14.5%
Earnings release date:08 Nov. 23
Europe, C.I.S., Africa, Middle East (EMEA):
2,002,000,000 €+20.0%
Americas:
2,505,000,000 €+16.0%
Asia, Australia:
–
Asia Pacific Japan:
831,000,000 €+25.7%
China:
717,000,000 €+0.8%
Total:
6,055,000,000 €+16.4%
Earnings release date:02 Aug. 23
Europe, C.I.S., Africa, Middle East (EMEA):
1,669,000,000 €-0.9%
Americas:
2,160,000,000 €+0.9%
Asia, Australia:
–
Asia Pacific Japan:
661,000,000 €-16.9%
China:
711,000,000 €-1.9%
Total:
5,201,000,000 €-2.7%
Earnings release date:10 May. 23
Europe, C.I.S., Africa, Middle East (EMEA):
1,685,000,000 €+3.3%
Americas:
2,140,000,000 €+4.0%
Asia, Australia:
–
Asia Pacific Japan:
795,000,000 €+10.1%
China:
725,000,000 €+8.7%
Total:
5,345,000,000 €+5.3%
Earnings release date:02 Feb. 23
Europe, C.I.S., Africa, Middle East (EMEA):
1,631,000,000 €-10.1%
Americas:
2,057,000,000 €-13.1%
Asia, Australia:
–
Asia Pacific Japan:
722,000,000 €
China:
667,000,000 €
Total:
5,077,000,000 €-15.4%
Earnings release date:09 Nov. 22
Europe, C.I.S., Africa, Middle East (EMEA):
1,814,000,000 €+21.4%
Americas:
2,368,000,000 €-0.3%
Asia, Australia:
1,817,000,000 €+37.9%
Asia Pacific Japan:
–
China:
–
Total:
5,999,000,000 €+15.7%
Earnings release date:03 Aug. 22
Europe, C.I.S., Africa, Middle East (EMEA):
1,494,000,000 €
Americas:
2,374,000,000 €
Asia, Australia:
1,318,000,000 €
Asia Pacific Japan:
–
China:
–
Total:
5,186,000,000 €

Operating expenses

Operating expensesTable view

Earnings release date
Cost of sales
Research and development expenses
Selling and general administrative expenses
Other operating expenses
Total
Earnings release date:07 May. 26
Cost of sales:
3,539,000,000 €+6.4%
Research and development expenses:
486,000,000 €+2.1%
Selling and general administrative expenses:
963,000,000 €+4.1%
Other operating expenses:
8,000,000 €+33.3%
Total:
4,996,000,000 €+5.6%
Earnings release date:05 Feb. 26
Cost of sales:
3,326,000,000 €-15.8%
Research and development expenses:
476,000,000 €-4.6%
Selling and general administrative expenses:
925,000,000 €-5.1%
Other operating expenses:
6,000,000 €-45.5%
Total:
4,733,000,000 €-12.9%
Earnings release date:05 Nov. 25
Cost of sales:
3,948,000,000 €+13.4%
Research and development expenses:
499,000,000 €+1.2%
Selling and general administrative expenses:
975,000,000 €+3.0%
Other operating expenses:
11,000,000 €+10.0%
Total:
5,433,000,000 €+10.2%
Earnings release date:30 Jul. 25
Cost of sales:
3,481,000,000 €-2.9%
Research and development expenses:
493,000,000 €+1.6%
Selling and general administrative expenses:
947,000,000 €-4.4%
Other operating expenses:
10,000,000 €+25.0%
Total:
4,931,000,000 €-2.7%
Earnings release date:07 May. 25
Cost of sales:
3,586,000,000 €+7.7%
Research and development expenses:
485,000,000 €+0.8%
Selling and general administrative expenses:
991,000,000 €+1.8%
Other operating expenses:
8,000,000 €+60.0%
Total:
5,070,000,000 €+5.9%
Earnings release date:06 Feb. 25
Cost of sales:
3,330,000,000 €-15.1%
Research and development expenses:
481,000,000 €-3.0%
Selling and general administrative expenses:
973,000,000 €+1.1%
Other operating expenses:
5,000,000 €-37.5%
Total:
4,789,000,000 €-11.1%
Earnings release date:06 Nov. 24
Cost of sales:
3,921,000,000 €+17.6%
Research and development expenses:
496,000,000 €+2.5%
Selling and general administrative expenses:
962,000,000 €+4.8%
Other operating expenses:
8,000,000 €-42.9%
Total:
5,387,000,000 €+13.4%
Earnings release date:31 Jul. 24
Cost of sales:
3,333,000,000 €-2.8%
Research and development expenses:
484,000,000 €+2.1%
Selling and general administrative expenses:
918,000,000 €+2.1%
Other operating expenses:
14,000,000 €-71.4%
Total:
4,749,000,000 €-2.1%
Earnings release date:07 May. 24
Cost of sales:
3,429,000,000 €+6.8%
Research and development expenses:
474,000,000 €+2.2%
Selling and general administrative expenses:
899,000,000 €-0.3%
Other operating expenses:
49,000,000 €+512.5%
Total:
4,851,000,000 €+5.8%
Earnings release date:01 Feb. 24
Cost of sales:
3,211,000,000 €-14.7%
Research and development expenses:
464,000,000 €-4.3%
Selling and general administrative expenses:
902,000,000 €-4.2%
Other operating expenses:
8,000,000 €-27.3%
Total:
4,585,000,000 €-11.9%
Earnings release date:08 Nov. 23
Cost of sales:
3,764,000,000 €+15.3%
Research and development expenses:
485,000,000 €+2.3%
Selling and general administrative expenses:
942,000,000 €+6.9%
Other operating expenses:
11,000,000 €-26.7%
Total:
5,202,000,000 €+12.2%
Earnings release date:02 Aug. 23
Cost of sales:
3,265,000,000 €-12.3%
Research and development expenses:
474,000,000 €+1.9%
Selling and general administrative expenses:
881,000,000 €-2.4%
Other operating expenses:
15,000,000 €-78.9%
Total:
4,635,000,000 €-10.2%
Earnings release date:10 May. 23
Cost of sales:
3,723,000,000 €+15.6%
Research and development expenses:
465,000,000 €+5.4%
Selling and general administrative expenses:
903,000,000 €+2.4%
Other operating expenses:
71,000,000 €+195.8%
Total:
5,162,000,000 €+13.0%
Earnings release date:02 Feb. 23
Cost of sales:
3,220,000,000 €-12.5%
Research and development expenses:
441,000,000 €-11.3%
Selling and general administrative expenses:
882,000,000 €-6.1%
Other operating expenses:
24,000,000 €+166.7%
Total:
4,567,000,000 €-10.9%
Earnings release date:09 Nov. 22
Cost of sales:
3,678,000,000 €+10.9%
Research and development expenses:
497,000,000 €+14.0%
Selling and general administrative expenses:
939,000,000 €+11.8%
Other operating expenses:
9,000,000 €+125.0%
Total:
5,123,000,000 €+11.4%
Earnings release date:03 Aug. 22
Cost of sales:
3,317,000,000 €
Research and development expenses:
436,000,000 €
Selling and general administrative expenses:
840,000,000 €
Other operating expenses:
4,000,000 €
Total:
4,597,000,000 €

Profitability

ProfitabilityTable view

Earnings release date
Net income (shareholders)
Free cash flow
Total
Earnings release date:07 May. 26
Net income (shareholders):
506,000,000 €+12.7%
Free cash flow:
390,000,000 €+17.8%
Total:
896,000,000 €+14.9%
Earnings release date:05 Feb. 26
Net income (shareholders):
449,000,000 €-23.6%
Free cash flow:
331,000,000 €-61.6%
Total:
780,000,000 €-46.2%
Earnings release date:05 Nov. 25
Net income (shareholders):
588,000,000 €+6.5%
Free cash flow:
863,000,000 €+2.3%
Total:
1,451,000,000 €+3.9%
Earnings release date:30 Jul. 25
Net income (shareholders):
552,000,000 €+4.2%
Free cash flow:
844,000,000 €+326.3%
Total:
1,396,000,000 €+91.8%
Earnings release date:07 May. 25
Net income (shareholders):
530,000,000 €+11.8%
Free cash flow:
198,000,000 €-75.6%
Total:
728,000,000 €-43.3%
Earnings release date:06 Feb. 25
Net income (shareholders):
474,000,000 €-23.1%
Free cash flow:
810,000,000 €-33.9%
Total:
1,284,000,000 €-30.3%
Earnings release date:06 Nov. 24
Net income (shareholders):
616,000,000 €+31.3%
Free cash flow:
1,226,000,000 €+124.5%
Total:
1,842,000,000 €+81.5%
Earnings release date:31 Jul. 24
Net income (shareholders):
469,000,000 €+10.1%
Free cash flow:
546,000,000 €+355.0%
Total:
1,015,000,000 €+85.9%
Earnings release date:07 May. 24
Net income (shareholders):
426,000,000 €-1.2%
Free cash flow:
120,000,000 €-49.6%
Total:
546,000,000 €-18.4%
Earnings release date:01 Feb. 24
Net income (shareholders):
431,000,000 €-19.7%
Free cash flow:
238,000,000 €-57.3%
Total:
669,000,000 €-38.8%
Earnings release date:08 Nov. 23
Net income (shareholders):
537,000,000 €+20.7%
Free cash flow:
557,000,000 €+95.4%
Total:
1,094,000,000 €+49.9%
Earnings release date:02 Aug. 23
Net income (shareholders):
445,000,000 €+323.8%
Free cash flow:
285,000,000 €-44.8%
Total:
730,000,000 €+17.6%
Earnings release date:10 May. 23
Net income (shareholders):
105,000,000 €-75.1%
Free cash flow:
516,000,000 €+770.1%
Total:
621,000,000 €+80.5%
Earnings release date:02 Feb. 23
Net income (shareholders):
421,000,000 €-33.2%
Free cash flow:
-77,000,000 €-117.0%
Total:
344,000,000 €-68.3%
Earnings release date:09 Nov. 22
Net income (shareholders):
630,000,000 €+73.6%
Free cash flow:
454,000,000 €-5.0%
Total:
1,084,000,000 €+28.9%
Earnings release date:03 Aug. 22
Net income (shareholders):
363,000,000 €
Free cash flow:
478,000,000 €
Total:
841,000,000 €

Profit margin in %

Profit margin in %Table view

Earnings release date
Profit margin (shareholders)
Profit margin (free cash flow)
Earnings release date:07 May. 26
Profit margin (shareholders):
8.91 %+0.6 pp
Profit margin (free cash flow):
6.87 %+0.7 pp
Earnings release date:05 Feb. 26
Profit margin (shareholders):
8.31 %-1.0 pp
Profit margin (free cash flow):
6.13 %-7.5 pp
Earnings release date:05 Nov. 25
Profit margin (shareholders):
9.3 %-0.4 pp
Profit margin (free cash flow):
13.65 %-1.3 pp
Earnings release date:30 Jul. 25
Profit margin (shareholders):
9.75 %+0.8 pp
Profit margin (free cash flow):
14.9 %+11.6 pp
Earnings release date:07 May. 25
Profit margin (shareholders):
8.97 %+0.3 pp
Profit margin (free cash flow):
3.35 %-11.4 pp
Earnings release date:06 Feb. 25
Profit margin (shareholders):
8.65 %-1.1 pp
Profit margin (free cash flow):
14.78 %-4.6 pp
Earnings release date:06 Nov. 24
Profit margin (shareholders):
9.74 %+1.1 pp
Profit margin (free cash flow):
19.38 %+9.3 pp
Earnings release date:31 Jul. 24
Profit margin (shareholders):
8.65 %+0.8 pp
Profit margin (free cash flow):
10.07 %+7.9 pp
Earnings release date:07 May. 24
Profit margin (shareholders):
7.84 %-0.5 pp
Profit margin (free cash flow):
2.21 %-2.4 pp
Earnings release date:01 Feb. 24
Profit margin (shareholders):
8.33 %-0.5 pp
Profit margin (free cash flow):
4.6 %-4.6 pp
Earnings release date:08 Nov. 23
Profit margin (shareholders):
8.87 %+0.3 pp
Profit margin (free cash flow):
9.2 %+3.7 pp
Earnings release date:02 Aug. 23
Profit margin (shareholders):
8.56 %+6.6 pp
Profit margin (free cash flow):
5.48 %-4.2 pp
Earnings release date:10 May. 23
Profit margin (shareholders):
1.96 %-6.3 pp
Profit margin (free cash flow):
9.65 %+11.2 pp
Earnings release date:02 Feb. 23
Profit margin (shareholders):
8.29 %-2.2 pp
Profit margin (free cash flow):
-1.52 %-9.1 pp
Earnings release date:09 Nov. 22
Profit margin (shareholders):
10.5 %+3.5 pp
Profit margin (free cash flow):
7.57 %-1.6 pp
Earnings release date:03 Aug. 22
Profit margin (shareholders):
7 %
Profit margin (free cash flow):
9.22 %